Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-02-2022 | Mefloquine | Case report

Mefloquine/sulfasalazine

Progressive multifocal leukoencephalopathy and interstitial pneumonia: case report

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Okazaki T, et al. Progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis under salazosulfapyridine treatment. [Japanese]. Rinsho Shinkeigaku 61: 833-838, No. 12, Dec 2021. Available from: URL: http://doi.org/10.5692/CLINICALNEUROL.CN-001622 [Japanese; summarised from an English abstract] Okazaki T, et al. Progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis under salazosulfapyridine treatment. [Japanese]. Rinsho Shinkeigaku 61: 833-838, No. 12, Dec 2021. Available from: URL: http://​doi.​org/​10.​5692/​CLINICALNEUROL.​CN-001622 [Japanese; summarised from an English abstract]
Metadata
Title
Mefloquine/sulfasalazine
Progressive multifocal leukoencephalopathy and interstitial pneumonia: case report
Publication date
01-02-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-10321-5

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Fampridine

Case report

Aspirin

Case report

Teriflunomide